Moderna is seeking a Director to establish and operationalize a centralized Bioassay Center of Excellence (CoE). This role involves building high-throughput, GxP-ready bioassay capabilities, leading daily operations, and driving the design, implementation, and scale-up of a fully automated facility. The director will convert complex assay science into scalable operations, collaborate across Analytical Development, QC, Automation Engineering, Quality, and external partners, and engage with digital and automation systems, including Generative AI-enabled lab systems.
Build, lead, and develop a high-performing multidisciplinary bioassay operations team (scientists, automation technologists, analysts, supervisors).,Oversee execution of critical assay types (IVRPE, IVRPA, REDA) supporting stability, release, and characterization.,Define and own key operational metrics (throughput, TAT, % automation coverage, assay reproducibility, cost per result) and drive continuous improvement.,Implement and govern GxP-ready infrastructure across SOPs, ELN templates, LIMS integration, barcoding, and sample chain-of-custody workflows.,Execute workforce planning, recruiting, and training strategies aligned to automated operations.,Serve as bioassay and operations lead in the design, build, and launch of the centralized Bioassay CoE (facility input, equipment selection, FAT/SAT planning, validation, Go-Live).,Lead cross-functional integration with Quality, Facilities, Automation Engineering, Analytical Development, IT, Supply Chain, and EHS.,Develop and implement an operating model supporting flexible deployment of GMP and non-GMP testing within shared lab space.,Collaborate with automation and digital teams to embed next-generation tools, including Generative AI capabilities.
[object Object]
Bachelor's Degree (minimum), PhD preferred
Must be a U.S. person (citizen, permanent resident, asylee, or refugee) due to U.S. export control laws (EAR) and access to controlled technology/data.,Moderna is unable to sponsor non-U.S. persons for an export control license.
Moderna is a biotechnology company pioneering a new class of medicines made of messenger RNA (mRNA). The company's platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and autoimmune diseases.
BerryMap uses cookies to provide essential features, analyze usage, and improve your experience. You can customize your preferences below.